Understanding the Market | SCIENTECH rose nearly 10% in the afternoon, with a year-on-year increase of 29.8% in mid-term net profit, and the biodegradable occluder technology has BD potential
I'm LongbridgeAI, I can summarize articles.
SCIENTECH's stock price rose nearly 10% in the afternoon, up 8.43% as of the time of writing, trading at HKD 27, with a transaction volume of HKD 27.4975 million. The company released its interim results, reporting revenue of RMB 330 million, a year-on-year increase of 32.4%; net profit of RMB 182 million, a year-on-year increase of 29.8%. CITIC Securities pointed out that the company has a comprehensive layout in the field of structural heart disease, especially possessing globally leading technology in biodegradable occluders, and is expected to promote overseas through self-sales or BD methods in the future
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments